Children, Adolescents and Young Adults with Myeloproliferative Neoplasia: Study of Clinico-biological Characteristics and Complications (VYP)
RecruitingOBSERVATIONAL
Enrollment
200
Participants
Timeline
Start Date
April 1, 2023
Primary Completion Date
April 1, 2038
Study Completion Date
April 1, 2038
Conditions
Myeloproliferative Neoplasm
Trial Locations (1)
29609
RECRUITING
CHU de Brest, Brest
All Listed Sponsors
lead
University Hospital, Brest
OTHER
NCT06715267 - Children, Adolescents and Young Adults with Myeloproliferative Neoplasia: Study of Clinico-biological Characteristics and Complications (VYP) | Biotech Hunter | Biotech Hunter